Profile data is unavailable for this security.
About the company
GUIZHOU YIBAI PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the production and distribution of pharmaceuticals. The Company provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules and tablets, among others. The company's products are applied in the treatment of cancer, cardiovascular and cerebrovascular, orthopedics, digestion, gynecology, children and breathing, among others. The Company mainly conducts its businesses within domestic markets.
- Revenue in CNY (TTM)2.40bn
- Net income in CNY-235.62m
- Incorporated2000
- Employees5.51k
- LocationGuizhou Yibai Pharmaceutical Co LtdNo. 220-1 Baiyun Avenue, Yunyan DistrictGUIYANG 550008ChinaCHN
- Phone+86 85 184705177
- Fax+86 85 184719910
- Websitehttps://www.gzcci.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Frontier Biotechnologies Inc | 122.86m | -316.34m | 2.72bn | 395.00 | -- | 2.30 | -- | 22.16 | -0.8445 | -0.8445 | 0.328 | 3.16 | 0.057 | 1.43 | 2.91 | 311,049.00 | -14.67 | -14.05 | -17.86 | -15.78 | 31.82 | 2.35 | -257.47 | -450.08 | 2.11 | -- | 0.2763 | -- | 34.82 | 126.63 | 7.79 | -- | 28.13 | -- |
| Ningbo Menovo Pharmaceutical Co Ltd | 1.24bn | 20.30m | 2.92bn | 2.35k | 153.22 | 1.34 | -- | 2.36 | 0.087 | 0.087 | 5.70 | 9.92 | 0.267 | 1.18 | 4.91 | 525,730.80 | 0.5164 | 4.94 | 0.7951 | 7.83 | 29.01 | 35.39 | 1.93 | 13.71 | 0.7203 | 4.44 | 0.4199 | 10.78 | -16.51 | 7.46 | -96.58 | -34.53 | -6.03 | -32.54 |
| Henan Taloph Pharmaceutical Stock Co Ltd | 1.97bn | 89.38m | 2.94bn | 2.35k | 33.87 | 1.87 | -- | 1.50 | 0.1515 | 0.1515 | 3.39 | 2.74 | 0.5571 | 2.93 | 2.06 | 836,256.80 | 2.67 | 0.272 | 5.80 | 0.4981 | 27.64 | 27.97 | 4.79 | 0.5501 | 0.8146 | 2.65 | 0.3911 | 28.70 | 5.57 | 11.62 | 160.32 | -- | -8.27 | -- |
| GuiZhou YiBai Pharmaceutical Co., Ltd. | 2.40bn | -235.62m | 2.95bn | 5.51k | -- | 1.12 | -- | 1.23 | -0.2975 | -0.2975 | 3.03 | 3.34 | 0.5288 | 1.52 | 13.04 | 435,209.10 | -5.39 | 0.8648 | -6.97 | 1.18 | 61.81 | 74.87 | -10.19 | 1.45 | 1.36 | -9.98 | 0.2375 | 216.36 | 3.12 | -6.19 | 124.25 | -- | -16.51 | -- |
| Shanghai MicuRx Pharmaceutical Co Ltd | 120.07m | -467.96m | 3.11bn | 205.00 | -- | 5.48 | -- | 25.92 | -0.7142 | -0.7142 | 0.1833 | 0.8664 | 0.1067 | 0.623 | 4.76 | 585,689.70 | -41.57 | -- | -45.49 | -- | 81.88 | -- | -389.75 | -- | 6.43 | -- | 0.3488 | -- | 88.31 | -- | -91.16 | -- | -- | -- |
| ChengDu Sheng Nuo Biotec Co Ltd | 481.63m | 92.49m | 3.14bn | 1.13k | 33.83 | 3.42 | -- | 6.51 | 0.8279 | 0.8279 | 4.31 | 8.20 | 0.3401 | 0.862 | 3.96 | 426,977.70 | 6.52 | 7.47 | 8.67 | 9.44 | 59.92 | 70.52 | 19.17 | 15.82 | 0.8466 | 13.35 | 0.32 | 21.83 | 9.93 | 9.37 | 9.08 | 18.69 | 54.71 | -- |
Data as of Nov 01 2024. Currency figures normalised to Guizhou Yibai Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 806.80k | 0.10% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2024 | 746.60k | 0.09% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2024 | 738.00k | 0.09% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 216.50k | 0.03% |
| Nuode Asset Management Co., Ltd.as of 30 Jun 2024 | 118.12k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 67.80k | 0.01% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 44.30k | 0.01% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 39.60k | 0.01% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2024 | 24.70k | 0.00% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 19.70k | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
